Objectives Define the major types of shock and principles of management Review fluid resuscitation, vasopressors and inotropes Address the balance of O 2 supply and demand Discuss the differential diagnosis of oliguria SHK 2
SHK 3
Shock Always a symptom of its cause Abnormally low organ perfusion usually associated with decreased blood pressure Signs of organ hypoperfusion: mental status change, oliguria, acidosis SHK 3
Distributive Shock Normal or increased cardiac output Low systemic vascular resistance Low to normal filling pressures Sepsis, anaphylaxis, neurogenic, and acute adrenal insufficiency SHK 7
Cardiogenic Shock Management Treat arrhythmias Diastolic dysfunction may require increased filling pressures Vasodilators if not hypotensive Inotrope administration SHK 10
Cardiogenic Shock Management Vasopressors if hypotensive to raise aortic diastolic pressure Mechanical assistance Consultation SHK 11
Hypovolemic Shock Volume resuscitation crystalloid, colloid Initial crystalloid choices Lactated Ringers solution Normal saline (high chloride may produce hyperchloremic acidosis) Match fluid given to fluid lost Blood, crystalloid, colloid
SHK 11
SHK 12
Distributive Shock Therapy Expand intravascular volume Hypotension despite volume therapy Inotropes Vasopressors for MAP < 60 mm Hg Adjunctive antibiotics in sepsis SHK 12
SHK 13
Obstructive Shock Treatment Relieve obstruction Pericardiocentesis Tube thoracostomy Treat pulmonary embolus Temporary benefit from fluid or inotrope administration SHK 14
Therapeutic Goals in Shock Increase O 2 delivery Optimize O 2 content of blood Improve cardiac output and blood pressure Match systemic O 2 needs with O 2 delivery Reverse/prevent organ hypoperfusion
SHK 15
Fluid Therapy Crystalloids Lactated Ringers solution Normal saline Colloids Hetastarch Albumin Packed red blood cells Infuse to physiologic endpoints
SHK 15
SHK 16
Fluid Therapy Correct hypotension first Decrease heart rate Correct hypoperfusion abnormalities Monitor for deterioration of oxygenation SHK 16
Inotropic Agent Dobutamine 5-20 g/kg/min Inotropic and variable chronotropic effect Decrease in systemic vascular resistance SHK 18
SHK 19
Inotropic / Vasopressor Agent Norepinephrine 0.05 g/kg/min and titrate Inotropic and vasopressor effects Potent vasopressor at high doses SHK 19
SHK 20
Epinephrine Both and actions for inotropic and vasopressor effects 0.1 g/kg/min and titrate Increases myocardial O 2
consumption SHK 20
SHK 21
Oliguria Marker of hypoperfusion Urine output in adults <0.5 mL/kg/hr for 2 hrs Etiologies Prerenal Renal Postrenal SHK 21
SHK 22
Evaluation of Oliguria History and physical examination Laboratory evaluation Urine sodium Urine osmolality or specific gravity BUN, creatinine SHK 22
SHK 23
Evaluation of Oliguria Laboratory Test Prerenal ATN Blood Urea Nitrogen/ >20 1020 Creatinine Ratio Urine Specific Gravity >1.020 <1.010 Urine Osmolality (mOsm/L) >500 <350 Urinary Sodium (mEq/L) <20 >40 Fractional Excretion of Sodium (%) <1 >2 SHK 24
Therapy in Acute Renal Insufficiency Correct underlying cause Monitor urine output Assure euvolemia Diuretics not therapeutic Low-dose dopamine? Adjust dosages of other drugs Monitor electrolytes, BUN, creatinine Consider dialysis SHK 24
SHK 25
Pediatric Considerations BP not good indication of hypoperfusion Capillary refill, extremity temperature better signs of poor systemic perfusion Epinephrine preferable to norepinephrine due to more chronotropic benefit from epinephrine Fluid boluses of 20 mL/kg titrated to BP or total 60 mL/kg, before inotropes or vasopressors Pediatric dosages in text SHK 25
SHK 26
Pediatric Considerations Neonates consider congenital obstructive left heart syndrome as cause of obstructive shock Oliguria < 2 yrs old, urine volume <2 mL/kg/hr Older children, urine volume <1 mL/kg/hr SHK 26